SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950170-24-127381
Filing Date
2024-11-15
Accepted
2024-11-15 06:02:36
Documents
7
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 6-K opt_-_opthea_agm_and_boa.htm 6-K 25593
2 PRESS RELEASE opt-ex99_1.htm EX-99.1 28516
3 PRESS RELEASE opt-ex99_2.htm EX-99.2 22748
4 PRESS RELEASE opt-ex99_3.htm EX-99.3 86215
5 PRESS RELEASE opt-ex99_4.htm EX-99.4 18504
6 GRAPHIC img260626642_0.jpg GRAPHIC 62433
7 GRAPHIC img260626642_1.jpg GRAPHIC 62433
  Complete submission text file 0000950170-24-127381.txt   354630
Mailing Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141
Business Address LEVEL 4 650 CHAPEL STREET SOUTH YARRA, VICTORIA C3 3141 61 3 9826 0399
Opthea Ltd (Filer) CIK: 0001815620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-39621 | Film No.: 241465727
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)